Justine Decroocq

1.4k total citations
22 papers, 278 citations indexed

About

Justine Decroocq is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Justine Decroocq has authored 22 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Justine Decroocq's work include Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Justine Decroocq is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Justine Decroocq collaborates with scholars based in France, United States and Switzerland. Justine Decroocq's co-authors include Didier Bouscary, Rudy Birsen, Éric Grignano, Nicolas Chapuis, Michaëla Fontenay, Olivier Kosmider, Lise Willems, Clément Larrue, Jean Emmanuel Sarry and Mathilde Gotanègre and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of the Rheumatic Diseases.

In The Last Decade

Justine Decroocq

18 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justine Decroocq France 8 141 124 93 76 66 22 278
Guifang Ouyang China 10 152 1.1× 32 0.3× 68 0.7× 76 1.0× 63 1.0× 42 276
Rabin Niroula United States 6 119 0.8× 29 0.2× 120 1.3× 43 0.6× 58 0.9× 23 284
Kota Yoshifuji Japan 6 111 0.8× 31 0.3× 57 0.6× 34 0.4× 53 0.8× 28 208
Nisha R. Pawar United States 6 117 0.8× 30 0.2× 52 0.6× 45 0.6× 72 1.1× 8 267
Guangyu Sun China 8 54 0.4× 60 0.5× 61 0.7× 44 0.6× 64 1.0× 39 213
Concetta Ingenito Italy 5 163 1.2× 26 0.2× 28 0.3× 57 0.8× 75 1.1× 12 259
Kriti Mittal United States 9 159 1.1× 136 1.1× 13 0.1× 106 1.4× 137 2.1× 28 360
Katjana Schwab Germany 12 74 0.5× 53 0.4× 38 0.4× 22 0.3× 142 2.2× 23 285
J.L. Merlin France 9 149 1.1× 29 0.2× 63 0.7× 30 0.4× 179 2.7× 22 299
Ernestina Tetteh United States 6 212 1.5× 58 0.5× 17 0.2× 32 0.4× 91 1.4× 6 343

Countries citing papers authored by Justine Decroocq

Since Specialization
Citations

This map shows the geographic impact of Justine Decroocq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justine Decroocq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justine Decroocq more than expected).

Fields of papers citing papers by Justine Decroocq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justine Decroocq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justine Decroocq. The network helps show where Justine Decroocq may publish in the future.

Co-authorship network of co-authors of Justine Decroocq

This figure shows the co-authorship network connecting the top 25 collaborators of Justine Decroocq. A scholar is included among the top collaborators of Justine Decroocq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justine Decroocq. Justine Decroocq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loap, Pierre, et al.. (2025). Exposure to the immune system during bridging radiotherapy for Car-T cells. Cancer/Radiothérapie. 29(2). 104595–104595.
2.
Dieudonné, Yannick, Emmanuel Chatelus, Thierry Martin, et al.. (2025). POS1121 THE USE OF THE CD3/CD19 T CELL ENGAGER BLINATUMOMAB IN SEVERE SYSTEMIC SCLEROSIS: A CASE SERIES. Annals of the Rheumatic Diseases. 84. 1203–1203.
3.
Tazi, Asmaa, Caroline Charre, A. Paugam, et al.. (2025). Prevention and management of infectious diseases in pregnant women with haematological malignancies. The Lancet Haematology. 12(10). e836–e849.
4.
Decroocq, Justine, Laurent Chouchana, Vassilis Tsatsaris, et al.. (2024). Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort study. The Lancet Haematology. 11(11). e850–e861. 2 indexed citations
5.
Durot, Éric, Damien Roos‐Weil, Adrien Chauchet, et al.. (2024). High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia. Blood. 143(26). 2804–2807. 3 indexed citations
6.
Bredin, Swann, et al.. (2024). Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies. Annals of Intensive Care. 14(1). 143–143. 1 indexed citations
7.
Bazinet, Alexandre, Courtney D. DiNardo, Álex Bataller, et al.. (2024). A retrospective comparison of abbreviated course “7+7” vs standard hypomethylating agent plus venetoclax doublets in older/unfit patients with newly diagnosed acute myeloid leukemia.. Journal of Clinical Oncology. 42(16_suppl). 6507–6507. 7 indexed citations
8.
Loap, Pierre, Ludovic De Marzi, Justine Decroocq, et al.. (2024). Proton Therapy Reduces the Effective Dose to Immune Cells in Mediastinal Hodgkin Lymphoma Patients. International Journal of Particle Therapy. 13. 100110–100110. 2 indexed citations
9.
Loap, Pierre, et al.. (2024). Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case report. Strahlentherapie und Onkologie. 200(11). 983–985. 1 indexed citations
10.
Simula, Luca, Fathia Mami‐Chouaib, Georges Bismuth, et al.. (2023). FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors. Cancer Immunology Research. 11(11). 1508–1523. 8 indexed citations
11.
Garciaz, Sylvain, Sarah Bertoli, David A. Sallman, et al.. (2023). Acute Myeloid Leukemia Patients Who Stopped Venetoclax or/and Azacytidine for Other Reasons Than Progression Have a Prolonged Treatment Free Remission and Overall Survival. a Filo Study. Blood. 142(Supplement 1). 161–161. 7 indexed citations
12.
Grignano, Éric, Jérémie Zerbit, Justine Decroocq, et al.. (2023). Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein. Cell Death Discovery. 9(1). 97–97. 38 indexed citations
13.
Zerbit, Jérémie, Antoine Meyer, Justine Decroocq, et al.. (2022). Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era. Viruses. 14(11). 2377–2377. 15 indexed citations
14.
Friedrich, Chloé, Juliette Gay, Marie Templé, et al.. (2022). PCR‐Fluo‐ASXL1‐FA: A fast, sensitive and inexpensive complementary method to detect ASXL1 mutations in haematological malignancies. International Journal of Laboratory Hematology. 44(5). 928–933.
15.
16.
Decroocq, Justine, Sylvain Garciaz, Amine Belhabri, et al.. (2022). Therapy related myeloid neoplasms (t-MNs) following PARP inhibitors (PARPi): Real-life experience.. Journal of Clinical Oncology. 40(16_suppl). 7057–7057. 1 indexed citations
17.
Birsen, Rudy, Clément Larrue, Justine Decroocq, et al.. (2021). APR-246 induces early cell death by ferroptosis in acute myeloid leukemia. Haematologica. 107(2). 403–416. 131 indexed citations
18.
19.
Henry, Benoît, Katia Ambert‐Balay, Pierre Pothier, et al.. (2014). Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia. BMC Infectious Diseases. 14(1). 239–239. 15 indexed citations
20.
Decroocq, Justine, Louis Marcellin, Camille Le Ray, & Lise Willems. (2014). Rescue Therapy With Romiplostim for Refractory Primary Immune Thrombocytopenia During Pregnancy. Obstetrics and Gynecology. 124(2). 481–483. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guifang Ouyang Breakdown of academic impact, for papers by Rabin Niroula Breakdown of academic impact, for papers by Kota Yoshifuji Breakdown of academic impact, for papers by Nisha R. Pawar Breakdown of academic impact, for papers by Guangyu Sun Breakdown of academic impact, for papers by Concetta Ingenito Breakdown of academic impact, for papers by Kriti Mittal Breakdown of academic impact, for papers by Katjana Schwab Breakdown of academic impact, for papers by J.L. Merlin Breakdown of academic impact, for papers by Ernestina Tetteh
Rankless by CCL
2026